Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in elderly COVID-19 patients
NCT04361643Phase 4Unknown
- Sponsor
- Hospital Universitario de Getafe
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Lenalidomide Arm with Placebo Arm (2 arms). Primary endpoints: Clinical improvement at 30 days and Immune-inflammatory improvement at 30 days. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04361643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361643.